FDA DEVICE FACTS
PENTAX MEDICAL ED-3490TK, Video Duodenoscope
Pentax Medical
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The ED‐3490TK, Video Duodenoscope, is intended to provide optical visualization (via a video monitor) of, and therapeutic access to the Biliary Tract via the Upper GI Tract. This anatomy includes, but is not restricted to, the organs; tissues; and subsystems: Esophagus, Stomach, Duodenum, Common Bile, Hepatic, and Cystic Ducts. This instrument is introduced via the mouth when indications consistent with the need for procedure are observed in adult and pediatric populations. Summary of Technology Characteristics: The optical properties and imaging characteristics remain unchanged since the prior submission. The differences between the subject and predicate devices are as follows:
• Distal end design differences (changes in materials and dimensions)
• Modifications to the device's reprocessing procedure and recommendation for annual maintenance. Safety and Performance Data (Non‐clinical tests): No performance standards or special controls applicable to this device have been adopted under Section 513 or 514 of the Federal Food, Drug, and Cosmetic Act. PENTAX Medical has conducted performance testing and design analysis to demonstrate the safety and effectiveness of the elevator wire channel seal, as well as the distal end cap seal strength and i ntegrity. No animal or clinical performance testing has been completed. Biocompatibility: Biocompatibility of the ED-3490TK was evaluated in accordance with ISO 10993-1. Software: Software changes were made to enhance functionality and do not raise new or different questions of safety and effectiveness. Changes were validated in accordance with FDA’s “Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices”. Reprocessing Validation: Validation of the cleaning, disinfection, and sterilization instructions was performed in accordance with FDA’s guidance, “Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling”. The following Technical Information Reports (TIRs) were referenced: AAMI TIR 12:2010, AAMI TIR30:2011. EMC and Electrical Safety: No changes have been made to the EMC or electrical safety as compared to prior submission (K092710).
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。